Skip to main content
Citadel Group logo

Citadel Group — Investor Relations & Filings

Ticker · CGL ISIN · AU000000CGL3 LEI · 213800FIHTDHRZIC4882 ASX Financial and insurance activities
Open in API
Filings indexed 2,090 across all filing types
Latest filing 2023-01-09 Major Shareholding Noti…
Country AU Australia
Listing ASX CGL

About Citadel Group

https://www.citadelgroup.com.au/

Citadel Group is a software and technology company specializing in secure enterprise information management for complex environments. The firm develops and delivers software applications, digital platforms, managed services, and IT solutions. It primarily serves government departments and large corporate clients, with a focus on managing system-critical data. The company also provides solutions for the healthcare sector aimed at improving patient outcomes. The organization has evolved and now operates under the name Citadel Edge.

Recent filings

Filing Released Lang Actions
Form 8.3 - Mediclinic International plc
Major Shareholding Notification Classification · 98% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory requirement under the UK Takeover Code for persons with interests in relevant securities representing 1% or more to disclose their positions and dealings during an offer period. This document details specific share transactions and derivative positions by Citadel Group regarding Mediclinic International plc. Since it is a specific regulatory disclosure form and does not fit into the other categories like M&A (TAR) or Shareholding Notification (MRQ) as perfectly as it fits the general regulatory filing category for such disclosures, it is classified as RNS.
2023-01-09 English
Form 8.3 - Mediclinic International plc
Major Shareholding Notification Classification · 100% confidence The document is a 'FORM 8.3' filing, which is a standard regulatory disclosure required under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree. It details shareholdings, derivatives, and specific dealings in the securities of 'Mediclinic International plc'. This type of disclosure is a specific regulatory requirement for market transparency during takeover situations and is distinct from general corporate reports or announcements.
2023-01-06 English
Form 8.3 - Mediclinic International plc
Major Shareholding Notification Classification · 100% confidence The document is a 'FORM 8.3' disclosure, which is a standard regulatory filing under the UK Takeover Code. It details the public opening position and dealing disclosure by a person with interests in relevant securities (Citadel Group) regarding an offeror/offeree (Mediclinic International plc). This type of document is a mandatory regulatory notification of shareholding and dealing activity during a takeover period, which falls under the 'Major Shareholding Notification' category as it tracks significant ownership and changes in interest levels.
2023-01-05 English
Form 8.3 - Homeserve PLC
Regulatory Filings Classification · 95% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory requirement under the UK Takeover Code for persons with interests in securities representing 1% or more of an offeror or offeree. This is a specific type of regulatory filing related to M&A activity (takeover disclosures). While it relates to M&A, it is a mandatory regulatory disclosure rather than a corporate M&A announcement (TAR). Given the specific nature of Rule 8.3 disclosures, it falls under the category of Regulatory Filings (RNS).
2023-01-04 English
Form 8.3 - Mediclinic International plc
Regulatory Filings Classification · 95% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory requirement under the UK Takeover Code for persons with interests in relevant securities representing 1% or more during an offer period. It details positions and dealings in the securities of Mediclinic International plc. Since this is a specific regulatory disclosure form required by the Takeover Panel and does not fit into categories like M&A activity (which would be the company's announcement) or director dealings, it is classified as a Regulatory Filing (RNS).
2023-01-04 English
Form 8.3 - Mediclinic International plc
Regulatory Filings Classification · 100% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing under the UK Takeover Code. It details the opening position and dealings in relevant securities by a person with interests representing 1% or more in a company involved in a takeover (Mediclinic International plc). This type of disclosure is a specific regulatory requirement for market surveillance and does not fit into categories like Annual Reports, Earnings Releases, or Director's Dealings. Therefore, it is classified as a Regulatory Filing (RNS).
2023-01-03 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.